The Cardiology Channel

Prasugrel Improves Ischemic Event Rates After Percutaneous Coronary Intervention

:59 | Cardiology, Cardiology: Interventional, Family Medicine, Hospitalist, Internal Medicine, Nurses/NP/PA, Pharmacists, Preventative Health, Surgery

The investigational antiplatelet agent Prasugrel improves ischemic event rates after percutaneous coronary intervention, whatever type of stent is used, researchers reported at the American College of Cardiology meeting.

References and Resources
American College of Cardiology

More in Cardiology

► 03:02

Repairing a Pediatric “Swiss Cheese Heart”

Cardiology

Cardiothoracic surgeon Dr. Emile Bacha describes and breaks down one of the most complicated cases of Swiss Cheese Septum seen at NewYork-Presbyterian Morgan Stanley Children's Hospital.

► 2:00:45

Athlete Respiratory Health

Cardiology

During the Athlete Respiratory Health session of the ISEH Annual Sports Cardio-Respiratory Medicine Conference, the speakers discussed respiratory health, the new IOC guideline on athlete respiratory health, how to protect...

► 02:00

The Cardiology Channel

Prasugrel Improves Ischemic Event Rates After Percutaneous Coronary Intervention

More in Cardiology

Repairing a Pediatric “Swiss Cheese Heart”

Cardiology

Athlete Respiratory Health

Cardiology

Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Did Not Meet Noninferiority Compared to Coronary Artery Bypass Surgery

Cardiology

CHANGE AFib Clinical Trial Will Implement Early Intervention in Patients Diagnosed with Atrial Fibrillation

Cardiology